Photo of Dr Aiman Haider

Dr Aiman Haider

Telephone:

Email:

Location:

  • University College Hospital

GMC/GDC number:

7061781

Professional background

Current post: Consultant pathologist (urological pathology)

Current positions: Education Secretary and Council member; British Association of Urological Pathologists
Member of EAU/ ESU Working Group
"Imaging, Focal, Uropathology" HSL/UCL research Innovations Committee

Prior to taking up a consultant post at UCLH, Dr Aiman Haider undertook “Marcel Levi’ research fellowship funded by Prostate Cancer UK centre of excellence award and UCLH charitable funds to provide the pathology role to many collaborative uro oncology, andrology translational research projects and interventional clinical trials including the 100K Genome Project, PRECISION, PRIME, NeuroSAFE, Histo-MRI.

Specialties

Research interests

  • Urological lesions
  • Prostate cancer
  • Bladder cancer
  • Penile and testicular cancer

Languages spoken

English, Urdu, Hindi

Publications

January 2024 (Most recent; https://pubmed.ncbi.nlm.nih.gov/?term=Aiman+Haider)

  1. Dear K, Kravvas G, Sim S, Mastoraki E, James M, Watchorn R, Haider A, Ellery P, Freeman A, Alnajjar HM, Muneer A, Bunker CB. Primary penile melanoma and genital lichen sclerosus. Skin Health Dis. 2023 Aug 12;3(6):e274. doi: 10.1002/ski2.274. PMID: 38047263; PMCID: PMC10690690.
  2. Au M, Almeida-Magana R, Al-Hammouri T, Haider A, Shaw G. Accuracy of Ex-vivo Fluorescence Confocal Microscopy in Margin Assessment of Solid Tumors: A Systematic Review. J Histochem Cytochem. 2023 Dec;71(12):661-674. doi: 10.1369/00221554231212948. Epub 2023 Nov 15. PMID: 37968920; PMCID: PMC10691410.
  3. Pang KH, Fallara G, Tang S, Haider A, Freeman A, Hadway P, Nigam R, Rees R, Mitra A, Alifrangis C, Bunker C, Alnajjar HM, Muneer A. Primary squamous cell carcinoma of the scrotum: Outcomes from a specialist center. Urol Oncol. 2023 Dec;41(12):488.e11-488.e18. doi: 10.1016/j.urolonc.2023.08.006. Epub 2023 Oct 29. PMID: 37903660.
  4. Giganti F, Dickinson L, Orczyk C, Haider A, Freeman A, Emberton M, Allen C, Moore CM. Prostate Imaging after Focal Ablation (PI-FAB): A Proposal for a Scoring System for Multiparametric MRI of the Prostate After Focal Therapy. Eur Urol Oncol. 2023 Dec;6(6):629-634. doi: 10.1016/j.euo.2023.04.007. Epub 2023 May 18. PMID: 37210343.
  5. Almeida-Magana R, Au M, Al-Hammouri T, Dinneen K, Haider A, Freeman A, Shaw G. Improving fluorescence confocal microscopy for margin assessment during robot-assisted radical prostatectomy: The LaserSAFE technique. BJU Int. 2023 Nov 27. doi: 10.1111/bju.16239. Epub ahead of print. PMID: 38009389.
  6. Woernle A, Englman C, Dickinson L, Kirkham A, Punwani S, Haider A, Freeman A, Kasivisivanathan V, Emberton M, Hines J, Moore CM, Allen C, Giganti F. Picture Perfect: The Status of Image Quality in Prostate MRI. J Magn Reson Imaging. 2023 Oct 7. doi: 10.1002/jmri.29025. Epub ahead of print. PMID: 37804007.
  7. Giganti F, Ng A, Asif A, Chan VW, Rossiter M, Nathan A, Khetrapal P, Dickinson L, Punwani S, Brew-Graves C, Freeman A, Emberton M, Moore CM, Allen C, Kasivisvanathan V; PRIME Quality Improvement Group. Global Variation in Magnetic Resonance Imaging Quality of the Prostate. Radiology. 2023 Oct;309(1):e231130. doi: 10.1148/radiol.231130. PMID: 37815448.
  8. ST6GAL1-mediated aberrant sialylation promotes prostate cancer progression. Scott E, Archer Goode E, Garnham R, Hodgson K, Orozco-Moreno M, Turner H, Livermore K, Putri Nangkana K, Frame FM, Bermudez A, Jose Garcia Marques F, McClurg UL, Wilson L, Thomas H, Buskin A, Hepburn A, Duxfield A, Bastian K, Pye H, Arredondo HM, Hysenaj G, Heavey S, Stopka-Farooqui U, Haider A, Freeman A, Singh S, Johnston EW, Punwani S, Knight B, McCullagh P, McGrath J, Crundwell M, Harries L, Heer R, Maitland NJ, Whitaker H, Pitteri S, Troyer DA, Wang N, Elliott DJ, Drake RR, Munkley J. J Pathol. 2023 Sep;261(1):71-84. doi: 10.1002/path.6152. Epub 2023 Aug 7. PMID: 37550801
  9. Buried calculi within the coronal sulcus in a circumcised patient. Pang KH, Fallara G, Haider A, Muneer A, Alnajjar HM. Br J Hosp Med (Lond). 2023 Jun 2;84(6):1. doi: 10.12968/hmed.2022.0558. Epub 2023 Jun 20. PMID: 37364873 No abstract available.
  10. Prostate Imaging after Focal Ablation (PI-FAB): A Proposal for a Scoring System for Multiparametric MRI of the Prostate After Focal Therapy. Giganti F, Dickinson L, Orczyk C, Haider A, Freeman A, Emberton M, Allen C, Moore CM. Eur Urol Oncol. 2023 May 18:S2588-9311(23)00083-4. doi: 10.1016/j.euo.2023.04.007. Online ahead of print. PMID: 37210343
  11. Outcomes of penile sarcomatoid squamous cell carcinoma from a single tertiary referral centre: a matched cohort study. Pang KH, Girling B, Osinibi E, Sawhney P, Haider A, Freeman A, Hadway P, Nigam R, Rees R, Mitra A, Muneer A, Alifrangis C, Alnajjar HM. BJU Int. 2023 Sep;132(3):337-342. doi: 10.1111/bju.16044. Epub 2023 Jun 1. PMID: 37169730
  12. Magnetic Resonance Imaging Follow-up of Targeted Biopsy-negative Prostate Lesions. Stavrinides V, Eksi E, Finn R, Texeira-Mendes L, Rana S, Trahearn N, Grey A, Giganti F, Huet E, Fiard G, Freeman A, Haider A, Allen C, Kirkham A, Cole AP, Collins T, Pendse D, Dickinson L, Punwani S, Pashayan N, Emberton M, Moore CM, Orczyk C. Eur Urol Focus. 2023 Apr 6:S2405-4569(23)00077-9. doi: 10.1016/j.euf.2023.03.011. Online ahead of print. PMID: 37031096
  13. Comparing biparametric to multiparametric MRI in the diagnosis of clinically significant prostate cancer in biopsy-naive men (PRIME): a prospective, international, multicentre, non-inferiority within-patient, diagnostic yield trial protocol. Asif A, Nathan A, Ng A, Khetrapal P, Chan VW, Giganti F, Allen C, Freeman A, Punwani S, Lorgelly P, Clarke CS, Brew-Graves C, Muirhead N, Emberton M, Agarwal R, Takwoingi Y, Deeks JJ, Moore CM, Kasivisvanathan V; PRIME Trial Group. BMJ Open. 2023 Apr 5;13(4):e070280. doi: 10.1136/bmjopen-2022-070280. PMID: 37019486 Free PMC article.
  14. Genital lichen sclerosus and melanoma; a systematic review. Sim SJY, Dear K, Mastoraki E, James M, Haider A, Ellery P, Freeman A, Alnajjar HM, Muneer A, Watchorn R, Kravvas G, Bunker CB. Skin Health Dis. 2022 Dec 11;3(2):e198. doi: 10.1002/ski2.198. eCollection 2023 Apr. PMID: 37013116 Free PMC article. Review.
  15. A semi-automated software program to assess the impact of second reads in prostate MRI for equivocal lesions: results from a UK tertiary referral centre. Woernle A, Dickinson L, Lelie S, Pendse D, Heffernan Ho D, Ramachandran N, Kirkham A, Von Stempel C, Punwani S, Wah So C, Withington J, Grey A, Collins T, Maffei D, Haider A, Freeman A, Emberton M, Piper JW, Moore CM, Hines J, Orczyk C, Allen C, Giganti F. Eur J Radiol. 2023 May;162:110796. doi: 10.1016/j.ejrad.2023.110796. Epub 2023 Mar 24. PMID: 37003197
  16. Rare primary prostate cancer presenting with testicular and hip pain. Au M, Almeida-Magana R, Al-Hammouri T, Haider A, Miskovic D, Shaw G. Lancet Oncol. 2023 Apr;24(4):e186. doi: 10.1016/S1470-2045(23)00002-5. PMID: 36990616 No abstract available.
  17. Accurate diagnosis of prostate cancer by combining Proclarix with magnetic resonance imaging. Morote J, Pye H, Campistol M, Celma A, Regis L, Semidey M, de Torres I, Mast R, Planas J, Santamaria A, Trilla E, Athanasiou A, Singh S, Heavey S, Stopka-Farooqui U, Freeman A, Haider A, Schiess R, Whitaker HC, Punwani S, Ahmed HU, Emberton M. BJU Int. 2023 Aug;132(2):188-195. doi: 10.1111/bju.15998. Epub 2023 Mar 21. PMID: 36855895